1. Home
  2. AIXC vs MDCX Comparison

AIXC vs MDCX Comparison

Compare AIXC & MDCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

AIXC

AIxCrypto Holdings Inc.

N/A

Current Price

$1.09

Market Cap

27.9M

Sector

Health Care

ML Signal

N/A

Logo Medicus Pharma Ltd.

MDCX

Medicus Pharma Ltd.

HOLD

Current Price

$0.42

Market Cap

23.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIXC
MDCX
Founded
1996
2008
Country
United States
United States
Employees
10
16
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
23.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
AIXC
MDCX
Price
$1.09
$0.42
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$14.50
AVG Volume (30 Days)
76.6K
1.7M
Earning Date
05-12-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.92
$0.25
52 Week High
$2.98
$3.69

Technical Indicators

Market Signals
Indicator
AIXC
MDCX
Relative Strength Index (RSI) 41.05 53.76
Support Level $1.02 $0.38
Resistance Level $1.50 $0.52
Average True Range (ATR) 0.14 0.05
MACD -0.02 0.00
Stochastic Oscillator 10.91 55.92

Price Performance

Historical Comparison
AIXC
MDCX

About AIXC AIxCrypto Holdings Inc.

AIxCrypto Holdings Inc is a technology infrastructure company focused on the convergence of artificial intelligence and blockchain-based programmable systems. The Company develops software platforms and programmable infrastructure designed to facilitate the tokenization of real-world assets (RWA) and the deployment of Embodied Artificial Intelligence (EAI) in commercial environments. Its mission is to serve as the regulated, programmable infrastructure layer connecting traditional capital markets with on-chain systems and AI-enabled commercial systems.

About MDCX Medicus Pharma Ltd.

Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.

Share on Social Networks: